Loading clinical trials...
Loading clinical trials...
Belgian Observational Study to Evaluate Storage and Voiding Symptoms Improvement in Male Subjects With Lower Urinary Tract Predominant Storage Symptoms (Overactive Bladder Syndrome) Being Treated With Solifenacin in Monotherapy or Combination
Conditions
Interventions
Solifenacin
Locations
15
Belgium
ASZ
Aalst, Belgium
ZNA Stuyvenberg
Antwerp, Belgium
Erasme
Brussels, Belgium
UZ Brussel
Brussels, Belgium
Private practice
Brussels, Belgium
AZ St. Monica
Deurne, Belgium
Start Date
December 1, 2011
Primary Completion Date
October 1, 2013
Completion Date
October 1, 2013
Last Updated
December 19, 2013
Lead Sponsor
Astellas Pharma Europe B.V.
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions